hepat
c
viru
hcv
identifi
main
caus
agent
posttransfus
nona
nonb
hepat
recent
develop
diagnost
assay
routin
serolog
screen
blood
donor
prevent
case
posttransfus
hepat
purpos
paper
comprehens
review
current
inform
regard
virolog
hcv
recent
find
genom
organ
relationship
virus
replic
hcv
ribonucl
acid
hcv
translat
hcv
polyprotein
express
process
discuss
also
review
viru
assembl
releas
variabl
hcv
classif
genotyp
geograph
distribut
hcv
genotyp
biolog
differ
hcv
genotyp
assay
use
hcv
genotyp
discuss
term
reliabl
consist
resuit
molecular
epidemiolog
hcv
infect
review
approach
hcv
epidemiolog
prove
valuabl
document
spread
hcv
differ
risk
group
evalu
altern
nonparenter
rout
transmiss
understand
origin
evolut
hcv
hepat
c
viru
hcv
identifi
main
caus
agent
posttransfus
nona
nonb
hepat
identif
hcv
led
develop
diagnost
assay
infect
base
either
detect
antibodi
recombin
polypeptid
express
clone
hcv
sequenc
direct
detect
viru
ribonucl
acid
rna
sequenc
polymeras
chain
reaction
pcr
use
primer
complimentari
hcv
genom
routin
serolog
screen
blood
donor
prevent
case
posttransfus
hepat
assay
antibodi
also
import
diagnost
tool
use
investig
preval
hcv
differ
risk
group
intraven
drug
user
patient
hemophilia
recipi
blood
product
conduct
epidemiolog
studi
hcv
transmiss
complet
genom
sequenc
hcv
determin
sever
isol
reveal
overal
genom
organ
relationship
rna
virus
deduc
possibl
method
replic
analog
relat
virus
possibl
although
studi
current
hamper
absenc
satisfactori
vitro
cultur
method
hcv
consequ
convent
virolog
studi
difficult
artifici
hcv
contain
positivesens
rna
genom
approxim
base
length
overal
genom
organ
presum
method
replic
similar
member
famili
flavivirida
particularli
code
singl
polyprotein
cleav
seri
presum
structur
nonstructur
protein
figur
role
differ
protein
infer
comparison
relat
virus
vitro
express
clone
hcv
sequenc
prokaryot
eukaryot
system
artifici
system
allow
investig
protein
express
cleavag
posttransl
modif
numer
positivestrand
rna
viru
famili
whose
code
capac
contain
within
singl
open
read
frame
orf
found
hcv
may
use
compar
tabl
among
human
virus
includ
picomavirida
eg
polioviru
coxsackieviru
b
hepat
viru
flavivirida
eg
dengu
fever
yellow
fever
viru
genom
virus
similar
organ
structur
protein
end
nonstructur
protein
end
howev
viru
famili
differ
genom
size
number
protein
produc
mechan
polyprotein
cleav
detail
mechan
genom
replic
exampl
genom
picornavirida
shorter
hcv
approxim
base
contain
four
nucleocapsid
protein
compar
singl
protein
hcv
nonenvelop
therefor
contain
homologu
two
hcvencod
hcv
glycoprotein
e
use
exclus
virusencod
proteas
cleav
polyprotein
differ
hcv
flavivirida
cleavag
structur
protein
thought
carri
host
cell
deriv
signalas
member
flavivirida
mani
featur
common
hcv
similar
genom
size
yellow
fever
viru
base
compar
hcv
packag
viralencod
glycoprotein
viru
envelop
el
homologu
flavivirus
membranebound
glycoprotein
call
ns
ns
stand
nonstructur
express
infect
cell
surfac
like
hcv
polyprotein
cleav
combin
viral
host
cell
proteas
although
close
sequenc
similar
hcv
known
virus
least
two
region
conserv
amino
acid
residu
provid
anoth
fundament
aspect
genom
organ
differ
flaviviru
picornaviru
famili
structur
untransl
region
utr
part
genom
involv
hcv
replic
initi
translat
cellular
ribosom
virusencod
polyprotein
pestivirus
hcv
show
evid
highli
structur
intern
basepair
produc
complex
set
stemloop
structur
thought
interact
variou
host
cell
viru
protein
replic
particular
studi
shown
picornavirida
recent
hcv
pestivirus
structur
involv
intern
initi
translat
bind
host
cell
ribosom
direct
translat
intern
methionin
aug
codon
contrast
strongli
translat
flaviviru
genom
act
much
like
cellular
messeng
rna
ribosom
bind
initi
occur
cap
end
rna
follow
scan
sequenc
direct
translat
commenc
first
aug
codon
structur
hcv
also
similar
pestivirus
flavivirus
except
low
buoyant
densiti
sucros
similar
report
pestivirus
attribut
case
heavili
glycosyl
extern
membran
glycoprotein
viru
envelop
contrast
flaviviru
envelop
glycoprotein
contain
site
nlink
glycosyl
virion
rel
dens
arrang
number
cleavag
site
hcv
polyprotein
similar
pestivirus
particularli
cleavag
protein
two
subunit
case
correspond
rna
polymeras
recent
two
distinct
rna
virus
discov
new
world
primat
tamarin
sanguini
monkey
speci
previous
shown
harbor
infecti
agent
caus
chronic
hepat
origin
deriv
inocul
plasma
surgeon
gb
chronic
hepat
unknown
etiolog
develop
part
genom
two
virus
provision
call
gbva
gbvb
show
measur
sequenc
similar
certain
region
hcv
exampl
sequenc
part
gbva
gbvb
show
sequenc
similar
homolog
region
hcv
posit
hcv
polyprotein
sequenc
similar
similarli
region
around
activ
site
rna
polymeras
includ
gdd
motif
posit
hcv
show
sequenc
similar
gbva
gbvb
nonstructur
region
similar
valu
greater
hcv
pestivirus
flavivirus
although
littl
homolog
found
comparison
region
genomeencod
structur
protein
ie
core
envelop
normal
highli
conserv
degre
related
hcv
positivestrand
rna
virus
formal
analyz
phylogenet
analysi
highli
conserv
part
genom
region
homologu
virus
encod
rnadepend
rna
polymeras
invari
contain
canon
gdd
motif
necessari
enzymat
activ
protein
comparison
sequenc
surround
motif
indic
close
relationship
hcv
gbva
gbvb
intermedi
degre
related
pestiviru
bovin
viral
diarrhea
viru
much
distant
related
fiavivirus
figur
remark
seri
plant
virus
structur
distinct
mammalian
viru
group
differ
genom
organ
rnadepend
rna
polymeras
amino
acid
sequenc
perhap
similar
hcv
flavivirus
hcv
replic
studi
use
varieti
experiment
techniqu
howev
littl
progress
made
toward
develop
practic
hcv
cultur
hcv
produc
obviou
cytopatholog
amount
hcv
releas
cell
infect
vitro
often
low
might
cell
use
cultur
repres
infect
vivo
product
infect
requir
combin
cytokin
growth
factor
might
present
liver
recreat
cell
cultur
observ
low
level
hcv
replic
might
detect
lymphocyt
hepatocyt
cell
line
indic
either
tropism
hcv
differ
cell
type
may
greater
first
imagin
viru
replic
detect
far
repres
full
replic
cycl
hcv
occur
vivo
transfect
fulllength
dna
sequenc
hcv
genom
might
expect
initi
full
replic
cycl
hcv
similar
experi
done
picornaviru
sequenc
howev
low
level
express
viru
protein
observ
complet
hcv
sequenc
transfect
transform
hepatocyt
hepatoma
cell
line
despit
evid
replic
hcv
genom
product
low
concentr
progeni
viru
particl
model
provid
import
experiment
system
futur
investig
hcv
replic
common
positivestrand
rna
virus
hcv
presum
replic
rna
genom
product
replic
intermedi
ie
rna
copi
complet
genom
synthes
activ
viral
encod
rnadepend
rna
polymeras
minusstrand
copi
would
use
gener
positivestrand
copi
templat
reus
sever
minusstrand
copi
synthes
infect
posit
strand
transcript
use
sever
time
produc
positivestrand
progeni
sequenc
way
singl
input
sequenc
may
amplifi
sever
thousandfold
although
initi
transcript
well
understood
positivestrand
rna
virus
picornavirida
inform
current
avail
rna
synthesi
hcv
fla
koonin
sourc
nonhcv
sequenc
gbva
gbvb
hcv
genotyp
la
lb
shown
align
use
program
clustal
phylogenet
analysi
done
use
program
protdist
pam
matrix
neighbor
drawtre
phylip
packag
vivirus
prime
hcv
lack
homopolymer
tract
poli
u
picornavirus
end
genom
wherea
end
variabl
contain
either
poli
u
poli
tract
possibl
neither
appear
case
relat
pestivirus
furthermor
appear
homologu
vpg
protein
picornavirida
reason
like
mechan
transcript
initi
hcv
differ
use
strandspecif
pcr
method
antisens
hcv
rna
sequenc
detect
liver
hcvinfect
patient
confirm
presum
method
replic
hcv
via
replic
intermedi
assay
provid
valuabl
techniqu
detect
hcv
replic
sensit
method
monitor
hcv
replic
viru
cultur
experi
way
investig
rang
cell
type
distribut
hcv
infect
hcvinfect
patient
particular
possibl
replic
extrahepat
site
propos
basi
assay
studi
review
lau
et
al
thought
play
signific
role
initi
regul
translat
larg
orf
hcv
region
approxim
base
long
combin
comput
analysi
nucleas
map
experi
studi
covari
led
propos
secondari
structur
model
part
genom
figur
use
method
research
predict
remark
similar
structur
pestivirus
despit
virtual
absenc
nucleotid
sequenc
similar
hcv
indic
import
overal
structur
region
interact
viral
cellular
protein
rna
sequenc
direct
evid
intern
initi
translat
obtain
vitro
translat
report
gene
downstream
sequenc
place
monoor
dicistron
vector
nonpair
tip
stemloop
structur
partial
complimentari
subunit
ribosom
rna
may
therefor
site
bind
intern
initi
intern
ribosom
entri
site
activ
consist
hypothesi
translat
initi
aug
methionin
codon
posit
evid
translat
variabl
number
aug
triplet
upstream
posit
although
product
small
protein
upstream
potenti
orf
may
play
role
regul
express
larg
orf
absenc
cell
cultur
system
hcv
inform
avail
express
process
hcv
protein
obtain
transfect
experi
clone
dna
sequenc
correspond
differ
protein
recent
direct
observ
cellular
distribut
properti
hcv
protein
detect
liver
plasma
vivo
transfect
prokaryot
eukaryot
cell
dna
copi
differ
part
hcv
genom
control
artifici
promot
allow
express
encod
protein
provid
use
techniqu
studi
synthesi
biochem
properti
tabl
ii
express
part
genom
cell
reticulocytelysatecontain
microsom
membran
lead
synthesi
polyprotein
cleavag
seri
protein
protein
identifi
capsid
protein
basi
comparison
relat
virus
express
protein
approxim
size
kd
assign
protein
nucleocapsid
protein
support
presenc
region
within
protein
contain
numer
basic
posit
charg
amino
acid
may
rnabind
properti
associ
encapsid
hcv
rna
viru
assembl
bind
core
protein
ribosom
rna
recent
report
use
similar
techniqu
express
put
envelop
protein
hcv
el
lead
synthesi
mammalian
cell
two
heterogen
protein
size
rang
kd
kd
respect
cleavag
capsid
protein
el
depend
addit
microsom
membran
impli
host
cell
signalas
role
process
step
size
greater
could
explain
amino
acid
sequenc
alon
support
biochem
evid
extens
glycosyl
protein
translat
larg
number
potenti
nlink
glycosyl
site
although
detail
site
use
extent
glycoprotein
moieti
modifi
whether
also
olink
glycosyl
await
biochem
analysi
two
cleavag
site
microsom
depend
recent
identifi
lead
product
protein
differ
size
amino
acid
residu
evid
intermolecular
associ
obtain
immunoprecipit
experi
antibodi
could
precipit
protein
nondenatur
condit
natur
signific
associ
unclear
although
current
evid
suggest
associ
predominantli
noncoval
occur
simpli
hydrophob
interact
membran
anchor
two
protein
recent
monoclon
antibodi
either
shown
coprecipit
also
evid
associ
vitro
translat
rest
genom
lead
product
protein
size
kd
correspond
respect
figur
tabl
ii
proteolyt
cleavag
pathway
gener
nonstructur
protein
mediat
extens
studi
sever
group
repres
possibl
target
antivir
treatment
serin
proteas
catalyz
cleavag
reaction
metalloproteinas
cleav
junction
cleavag
reaction
mediat
cleavag
mediat
occur
ci
wherea
reaction
occur
intermolecular
associ
rest
polyprotein
account
complex
sequenc
event
interact
nonstructur
protein
involv
cleavag
reaction
differ
detail
depend
experiment
method
use
howev
cleavag
may
sequenti
process
modul
activ
protein
proteas
activ
zinc
depend
contain
activ
site
depend
residu
therefor
ci
cleavag
junction
proteas
inactiv
act
tran
substrat
cleavag
reaction
shown
essenti
activ
proteas
natur
variat
effici
reaction
may
modul
pathogen
hcv
vivo
releas
cleav
site
vari
effici
activ
site
map
delet
experi
lie
amino
terminu
protein
residu
substrat
specif
serin
proteas
activ
defin
sequenc
comparison
mutagenesi
experi
gener
conform
consensu
sequenc
de
ct
sa
target
protein
evid
less
stringent
requir
specif
amino
acid
around
ci
cleavag
site
cleav
tran
sever
investig
describ
requir
protein
cofactor
activ
particular
appear
bind
necessari
least
cleavag
may
modul
activ
way
although
inform
proteolyt
cleavag
step
use
process
hcv
polyprotein
difficulti
associ
vitro
cultur
hcv
product
infecti
molecular
clone
hcv
far
prevent
detail
understand
site
hcv
replic
cell
process
viru
assembl
releas
cell
futur
research
reveal
natur
interact
capsid
protein
viru
rna
packag
assembl
provirion
posttransl
modif
envelop
protein
occur
cell
site
bud
hcv
cellular
membran
understand
replic
fulli
must
also
identifi
mechan
prime
rna
synthesi
end
genom
natur
primer
whether
circular
necessari
transcript
cell
cultur
system
investig
differ
neutral
cytopath
properti
hcv
avail
nucleotid
sequenc
comparison
type
assay
develop
sequenc
data
becom
princip
techniqu
character
differ
variant
hcv
type
analysi
fairli
easi
perform
especi
sinc
viru
sequenc
amplifi
pcr
directli
clinic
specimen
common
rna
virus
variant
hcv
show
consider
sequenc
variabl
mani
differ
consider
prototyp
hcv
hcvpt
differ
found
complet
genom
sequenc
extrem
diverg
variant
analyz
date
compar
observ
serotyp
human
positivestrand
rna
virus
polioviru
coxsackieviru
coronavirus
sequenc
variabl
evenli
distribut
throughout
viru
gene
tabl
apart
highli
conserv
nucleotid
amino
acid
sequenc
core
nucleocapsid
protein
greater
variabl
envelop
gene
tabl
iii
nucleotid
sequenc
comparison
complet
genom
subgenom
fragment
variant
shown
variant
hcv
obtain
japan
substanti
differ
hcvpt
variant
obtain
unit
state
comparison
complet
genom
sequenc
hcvj
hcvbk
japan
show
sequenc
similar
hcvpt
time
former
variant
classifi
japanes
type
type
ii
unit
state
hcvpt
hcvh
classifi
type
comparison
subgenom
region
hcv
el
core
sourc
sequenc
la
lb
lc
tr
comparison
conserv
subgenom
region
maximum
nucleotid
sequenc
diverg
wherea
highli
variabl
region
found
part
genom
encod
el
nucleotid
sequenc
amino
acid
sequenc
differ
provid
evid
least
six
major
group
hcv
sequenc
contain
seri
close
relat
cluster
sequenc
figur
current
wide
use
nomenclatur
hcv
variant
reflect
hierarchi
sequenc
relationship
differ
isol
base
previou
suggest
major
branch
phylogenet
tree
refer
type
subtyp
correspond
close
relat
sequenc
within
major
group
figur
although
sequenc
analyz
figur
equival
sequenc
relationship
exist
part
genom
type
number
subtyp
b
c
case
order
discoveri
therefor
sequenc
clone
chiron
assign
type
la
hcvj
hcvbk
type
lb
type
type
nomenclatur
close
follow
scheme
origin
describ
enomoto
type
basi
phylogenet
analysi
sequenc
core
noncod
region
approach
avoid
inconsist
earlier
system
easier
extend
new
genotyp
discov
genotyp
hcv
type
la
show
broad
worldwid
distribut
wherea
other
type
r
simmond
found
specif
geograph
region
blood
donor
patient
chronic
hepat
countri
western
europ
unit
state
frequent
infect
genotyp
la
lb
although
rel
frequenc
may
vari
trend
frequent
infect
type
lb
southern
eastern
europ
mani
european
countri
genotyp
distribut
vari
age
patient
reflect
rapid
chang
genotyp
distribut
time
within
singl
geograph
area
strike
geograph
chang
genotyp
distribut
appar
southeast
europ
turkey
mainli
type
lb
sever
countri
middl
east
part
north
central
africa
genotyp
predomin
exampl
high
frequenc
hcv
infect
found
egypt
almost
correspond
type
hcv
type
also
princip
genotyp
countri
yemen
kuwait
iraq
saudi
arabia
middl
east
zair
burundi
gabon
central
africa
hcv
genotyp
frequent
found
among
patient
nona
nonb
hepat
blood
donor
south
africa
found
rare
europ
elsewher
japan
taiwan
part
china
genotyp
lb
frequent
found
infect
type
l
japan
appear
confin
patient
hemophilia
receiv
commerci
usproduc
blood
product
factor
viii
xi
clot
concentr
geograph
distribut
type
vari
rare
found
japan
also
infrequ
taiwan
hong
kong
macau
howev
genotyp
found
increas
frequenc
countri
west
frequent
occur
singapor
account
hepat
infect
thailand
small
sampl
genotyp
found
bangladesh
eastern
india
type
africa
evid
consider
sequenc
divers
within
type
genotyp
least
differ
subtyp
type
identifi
nepal
india
bangladesh
genotyp
highli
restrict
geograph
rang
type
type
origin
found
hong
kong
shown
new
major
genotyp
sequenc
comparison
region
approxim
one
third
antihcvposit
blood
donor
hong
kong
infect
genotyp
equival
proport
neighbor
macau
sl
vietnam
seri
novel
genotyp
found
vietnam
genotyp
distinct
type
classifi
date
close
relat
type
genotyp
consist
overlap
geograph
rang
type
southeast
asia
numer
investig
conduct
possibl
differ
cours
diseas
associ
differ
hcv
genotyp
rate
develop
cirrhosi
hepatocellular
carcinoma
whether
certain
genotyp
less
like
respond
interferon
treatment
larg
number
clinic
investig
document
sever
progress
liver
diseas
patient
infect
wellcharacter
genotyp
type
la
lb
littl
evid
thu
far
variant
hcv
complet
nonpathogen
howev
possibl
variat
rate
diseas
progress
differ
genotyp
rout
frequenc
persontoperson
transmiss
differ
probabl
achiev
sustain
respons
antivir
treatment
would
indic
potenti
use
identifi
infect
genotyp
certain
clinic
situat
sever
clinic
studi
catalogu
varieti
factor
includ
genotyp
correl
sever
liver
diseas
show
predict
valu
respons
antivir
treatment
factor
frequent
shown
influenc
respons
interferon
treatment
includ
age
durat
infect
presenc
cirrhosi
treatment
genotyp
pretreat
level
circul
viral
rna
plasma
consist
find
report
sever
differ
group
use
varieti
type
assay
greatli
increas
rate
longterm
respons
found
treat
patient
infect
genotyp
compar
type
lb
exampl
chemello
et
al
found
longterm
month
normal
alanin
aminotransferas
level
achiev
patient
infect
type
variant
compar
infect
type
infect
type
studi
tsubota
et
al
infect
type
lb
presenc
cirrhosi
high
pretreat
viru
load
independ
associ
reduc
chanc
respons
rel
risk
respect
mechan
differ
genotyp
differ
respons
treatment
remain
obscur
treatment
interferon
know
whether
effect
drug
directli
antivir
whether
inhibit
viru
replic
secondari
increas
express
major
histocompat
complex
class
antigen
surfac
hepatocyt
greater
cytotox
tcell
activ
virusinfect
cell
elucid
mechan
action
interferon
whether
virolog
differ
genotyp
sensit
antivir
agent
await
cellcultur
model
hcv
infect
although
determin
nucleotid
sequenc
reliabl
method
identifi
differ
genotyp
hcv
method
practic
larg
clinic
studi
mani
publish
method
genotyp
base
amplif
viral
sequenc
clinic
specimen
either
use
typespecif
primer
select
amplifi
differ
genotyp
analyz
pcr
product
hybrid
genotypespecif
probe
use
restrict
fragment
length
polymorph
rflp
assay
differ
strength
weak
exampl
method
base
amplif
analysi
sequenc
advantag
sensit
region
highli
conserv
frequent
amplifi
hcvinfect
patient
part
genom
howev
nucleotid
differ
found
differ
genotyp
although
reliabl
differenti
six
major
genotyp
use
rflp
typespecif
probe
possibl
alway
possibl
reliabl
identifi
viru
subtyp
type
consist
differ
posit
allow
differenti
restrict
enzym
orbi
probe
innolipa
innogenet
zwijnaard
belgium
howev
sequenc
type
indistinguish
type
similarli
novel
subtyp
type
often
show
sequenc
ident
type
la
lb
small
proport
type
la
variant
ident
type
lb
vice
versa
type
method
base
code
region
core
reliabl
identifi
subtyp
well
major
genotyp
degre
sequenc
diverg
much
greater
tabl
iii
howev
amplifi
sequenc
code
region
genom
gener
difficult
sequenc
variabl
primerbind
site
may
reduc
effect
sequenc
amplif
pcr
nevertheless
variat
exploit
genotyp
assay
use
typespecif
primer
complimentari
variabl
region
core
gene
current
assay
identifi
differenti
type
la
lb
although
method
technic
complic
perform
reliabl
may
difficult
extend
great
rang
hcv
genotyp
describ
serolog
type
method
advantag
pcrbase
method
term
speed
simplic
sampl
prepar
use
simpl
equip
found
diagnost
virolog
laboratori
care
optim
reagent
assay
may
show
high
sensit
reproduc
exampl
typespecif
antibodi
peptid
detect
approxim
patient
nona
nonb
hepat
furthermor
assay
readili
extend
detect
new
genotyp
one
assay
reliabl
identifi
typespecif
antibodi
six
major
genotyp
although
antigen
similar
subtyp
current
preclud
separ
identif
type
la
lb
use
peptid
alon
contrast
highli
restrict
sequenc
divers
adjac
core
region
two
put
envelop
gene
highli
diverg
differ
variant
hcv
tabl
iii
show
threetofourtim
higher
rate
sequenc
chang
time
persist
infect
patient
protein
like
lie
outsid
viru
would
princip
target
humor
immun
respons
hcv
elicit
infect
chang
gene
may
alter
antigen
viru
allow
immun
escap
neutral
antibodi
therefor
account
high
degre
envelop
sequenc
variabl
observ
persist
natur
hcv
infect
support
model
observ
much
variabl
gene
concentr
discret
hypervari
region
possibl
reflect
pressur
viru
evad
immun
recognit
specif
site
hcv
may
neutral
experiment
evid
support
theori
includ
observ
variant
hcv
chang
gene
antigen
distinct
mani
case
vivo
appear
variant
differ
sequenc
hypervari
region
follow
develop
antibodi
specif
recogn
new
variant
one
report
persist
hcv
infect
develop
patient
defici
antibodi
respons
agammaglobulinemia
without
develop
sequenc
variabl
consist
role
antibodydriv
variat
immunocompet
person
hand
envelop
sequenc
obtain
sequenti
persist
infect
patient
sometim
show
signific
chang
wherea
other
variant
coexist
antibodi
recogn
correspond
hypervari
region
peptid
cytotox
tcell
respons
also
may
play
protect
role
hcv
infect
viru
infect
import
viru
clearanc
antibodi
respons
infect
although
circumstanti
evid
support
theori
immun
escap
addit
studi
need
confinn
plausibl
model
viru
persist
mani
current
uncertainti
may
resolv
satisfactori
vitro
neutral
assay
develop
hcv
enabl
effect
amino
acid
chang
envelop
gene
directli
investig
addit
inform
also
need
rel
import
humor
cellmedi
immun
hcv
determin
import
viru
clearanc
protect
reinfect
persist
infect
hcv
entail
continu
replic
hcv
year
decad
infect
hcv
carder
larg
number
replic
cycl
combin
rel
errorpron
rnadepend
rna
polymeras
lead
measur
sequenc
drift
hcv
time
exampl
interv
persist
infect
chimpanze
rate
sequenc
chang
genom
whole
per
site
per
year
similar
rate
calcul
sequenc
chang
half
genom
year
observ
human
carrier
crosssect
studi
use
molecular
clock
possibl
principl
calcul
time
diverg
hcv
variant
therefor
establish
degre
epidemiolog
related
exampl
find
rel
sequenc
differ
variant
infect
two
individu
would
provid
evid
recent
hcv
transmiss
sequenc
comparison
variabl
region
hcv
genom
use
document
transmiss
person
either
mother
child
within
famili
iatrogen
rout
sexual
contact
studi
possibl
transmiss
differ
risk
behavior
assess
measur
degre
related
hcv
recov
implic
person
phylogenet
analysi
nucleotid
sequenc
provid
formal
method
investig
relationship
sequenc
phylogenet
tree
produc
method
indic
degre
related
sequenc
branch
order
differ
lineag
show
like
evolutionari
histori
sampl
popul
exampl
cluster
hcv
sequenc
singl
phylogenet
group
among
recipi
hcvcontamin
blood
product
antid
immunoglobulin
still
appar
year
infect
figur
approach
hcv
epidemiolog
prove
valuabl
document
spread
hcv
differ
risk
group
evalu
altern
nonparenter
rout
tran
antid
ig
recipi
pt
figur
phylogenet
relationship
sequenc
region
patient
expos
implic
batch
antid
immunoglobulin
ig
epidemiolog
unrel
type
lb
variant
japan
j
unit
state
u
europ
e
sequenc
hepat
c
viru
recov
batch
antid
ig
donor
sequenc
variant
infect
suspect
donor
plasma
pool
use
manufactur
batch
phylogenet
analysi
done
segment
base
pair
posit
gene
amplifi
sequenc
analyz
previous
describ
sequenc
distanc
calcul
use
program
dnaml
data
set
contain
prototyp
hepat
c
viru
type
la
outgroup
sequenc
obtain
publish
sourc
mission
understand
origin
evolut
hcv
paper
attempt
review
rapidli
expand
area
research
hope
combin
basic
scienc
clinic
studi
may
eventu
lead
greater
understand
way
hcv
infect
may
prevent
cure
use
antivir
vaccin
inform
provid
clearli
form
basi
mani
develop
hepat
c
viru
core
protein
j
virol
